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The molecular mechanisms leading to male infertility in vitamin A deficient (VAD) rodents have never been fully elucidated. Here, we
report an interaction between BMP4 and retinoid signaling pathways in germ cells that may help clarify the biochemical basis of VAD. Adult
germ cells, in particular spermatogonia, expressed BMP4 at both the mRNA and protein levels. BMP4 expression was significantly up-
regulated in the testes of VAD mice and was down-regulated in freshly isolated germ cells and VAD testes by retinol, but not retinoic acid.
The retinoid-responsive gene, RARh, was not induced in germ cells following retinoid treatment. Examination of BMP4 promoter usage in
spermatogonia and the VAD testis revealed that germ cells utilize the recently characterized BMP4 intron 2 promoter, in addition to the
classical 1A and 1B promoters. The observed decrease in BMP4 in response to retinol was mediated by the 1A and intron 2 promoters of the
BMP4 gene. Our results reflect a direct requirement for retinoids by germ cells for the resumption of spermatogenesis in VAD animals via
mechanisms that involve the suppression of BMP4 expression.
D 2005 Elsevier Inc. All rights reserved.Keywords: Spermatogenesis; Retinoid signaling; BMP4; Vitamin A deficiency; TestisIntroduction
One of the essential roles of retinoids is in the regulation
of mammalian spermatogenesis (Huang and Hembree,
1979; Packer and Wolgemuth, 1999). Spermatogenesis
involves the differentiation of highly specialized haploid
spermatozoa from a population of spermatogonial stem
cells within the testis. Due to the complexity of the
pathways involved, the molecular mechanisms that regulate
this differentiation process remain poorly characterized.
This process is a classic example of stem cell differentiation
and it is completely, but not solely, reliant on adequate
vitamin A.
Wolbach and Howe (1925) first observed that vitamin A
deficient (VAD) rodents suffered various disorders includ-
ing blindness and male infertility. Further research has0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: sroman@mail.newcastle.edu.au (S.D. Roman).since revealed that vitamin A withdrawal leads to an arrest
in the transition of A spermatogonia to type A1 sperma-
togonia (reviewed in Chung and Wolgemuth 2004).
Supplementing the diet of these animals with retinoic acid
(RA) alleviates all symptoms of vitamin A deficiency, with
the exception of sight and spermatogenesis. It is not until
VAD animals are readministered retinol (ROL) through the
diet, or RA is injected in repeated high doses inter-
peritoneally, that normal spermatogenic function is restored
(Huang and Hembree, 1979; van Pelt and de Rooij, 1991).
In addition, ablation of the RA receptors RARa and RXRh
in the mouse also results in male sterility, while female
animals remain fertile (Kastner et al., 1996; Lufkin et al.,
1993). RARa-null mice have testis and seminiferous tubule
morphology similar to the VAD testis, while RXRb-null
mice exhibit seminiferous tubule degeneration (Kastner et
al., 1996; Lufkin et al., 1993). It can be concluded from
these studies that the mammalian testis is a major site of
retinoid action. However, it is unclear from the VAD or
knockout studies whether the germ cells are responding
directly to the retinoids or if the effect is mediated by286 (2005) 78 – 90
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retinoids during spermatogenesis. Thus, the exact mecha-
nism of vitamin A action in the male germ line remains to
be elucidated.
The transforming growth factor (TGF)-h superfamily is
known to be important in germ cell differentiation and
survival. The TGF-h superfamily consists of several ligand
classes, including the bone morphogenetic proteins (BMPs),
activins, inhibins, and the growth and differentiation factors
(Zimmerman and Padgett, 2000). Specific members of the
BMP family in particular have been implicated in various
aspects of spermatogenesis and germ cell survival. (Ying et
al., 2000; Zhao et al., 1996, 1998, 2001). One such example
is BMP4. In the mouse, targeted inactivation of the BMP4
gene results in a failure to form primordial germ cells
(PGCs) (Lawson et al., 1999; Ying et al., 2000), and its
presence is also necessary for PGC localization to the
genital ridge and PGC survival (Fujiwara et al., 2001). The
role of BMP4 in other stages of spermatogenesis is less well
characterized and requires further investigation.
Given the important roles of both the retinoid and
BMP signaling pathways in various cellular processes, it
is not surprising that in several systems they interact in
vitro and in vivo. For example, in P19 embryonal
carcinoma cells, BMP2 and BMP4 have been shown to
interact with RA signaling to induce apoptosis (Glozak
and Rogers, 1996; Glozak and Rogers, 2001). RA-induced
apoptosis mediated by BMP signaling is also known to
occur in inter-digital cell death of the fetal vertebrate limb
(Rodriguez-Leon et al., 1999). Several studies have
revealed that some of the malformations resulting from
RA-mediated teratogenicity, including cleft palate forma-
tion (Ho et al., 2004) and digestive tract abnormalities
(Sasaki et al., 2004), are due to regulation of the BMP4
by RA. Treatment of 10.5 d.p.c. whole mouse embryos
with RA also causes overall decreases in BMP4 mRNA
levels, indicating that BMP4 may mediate other aspects of
RA teratogenicity (Zhu et al., 1999). Furthermore, during
lung morphogenesis, RA regulation of BMP4 mRNA
levels is crucial for correct lung formation (Malpel et al.,
2000). RA-mediated down-regulation of BMP4 expression
has been observed in the developing limb bud (Mic et al.,
2003), and inner ear (Thompson et al., 2003). Together,
these studies demonstrate that the effect of retinoids on
BMP levels is cell type and tissue dependent, and that the
interaction between these pathways is critical to many
differentiative processes.
While it is evident that both retinoids and certain
members of the TGF-h superfamily are necessary for male
reproductive capacity, it is as yet unclear whether these
signaling pathways interact in the germ line. Here, we report
for the first time the characterization of BMP4 and retinoid
receptor expression in murine spermatogonia, and describe
an interaction between these two signaling systems that may
indicate a potential mechanism through which they regulate
spermatogenesis.Materials and methods
Animals, antibodies, chemicals, and reagents
The use of animals for this study was approved by the
University of Newcastle (Australia) Animal Care and
Ethics Committee. Mouse anti-human BMP4 monoclonal
antibody was obtained from R&D Systems (Minneapolis,
MN, USA), rat anti-mouse GCNA1 monoclonal antibody
supernatant was a kind gift from G. Enders (Kansas,
USA), and mouse anti-bovine vimentin was obtained
from BD Pharmingen (San Diego, CA, USA). All
chemicals and reagents were obtained from Sigma
(Sigma, St. Louis, MO, USA) or Research Organics
(Research Organics Inc., Cleveland, Ohio, USA) unless
otherwise stated. Cell culture reagents were from Sigma
and Gibco (Gibcoi Invitrogen Corporation, Mt. Waverly
Victoria, Australia). GC-1(spg) and P19 embryonal
carcinoma cells were purchased from ATCC (Manassas,
VA, USA).
Cell line culture and retinoid treatment of cell lines
GC-1(spg) and P19 embryonal carcinoma cells were
cultured in DMEM supplemented with 100 AM sodium
pyruvate, 200 AM l-glutamate, 100 U/ml penicillin, 10 Ag/
ml streptomycin, and 5% fetal bovine serum (FBS) for
routine culture, and 0.5% FBS for all experiments. Retinoids
were dissolved in 100% ethanol and diluted 1000-fold in
DMEM media supplemented with 0.5% FBS to obtain final
working concentrations. Stock solutions of all-trans-ROL
and all-trans-RA were prepared fresh weekly and stored in
the dark at 20-C.
Generation of vitamin A deficient mice
2-week-old male, Swiss, out-bred mice were weaned
onto a vitamin A deficient (VAD) diet (Vitamin A deficient
diet, modified. Catalogue number: 960220, MP Biomed-
icals). Mice were maintained on this diet until signs of
vitamin A deficiency were observed, normally at around 8
weeks, which included listlessness, piloerection, blindness,
diarrhea, and weight loss. Once deficiency was reached,
animals were either culled and their tissues removed for
histology and RNA isolation, or subjected to retinoid
administration. Treatments involved injecting mice with
either ROL, in the form of 0.5 mg retinyl acetate,
interperitoneally (i.p.) (in 1:5, DMSO:sesame oil) and
placing onto normal mouse food, or 0.5 mg all-trans-RA
i.p. and placing on an RA supplemented diet (10 mg/kg all-
trans-RA). At various times, mice were culled and one testis
employed for histological analysis, while the contra-lateral
testis was used for RNA extraction. For histological
analysis, tissue was fixed overnight by incubation in ice-
cold 4% paraformaldehyde in PBS at 4-C, then dehydrated
and embedding in paraffin.
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Sections were de-paraffinized and rehydrated. Antigen
retrieval was performed with 10 mM sodium citrate pH 6.0
at 95-C for 10 min. Slides were blocked in 1% H2O2 in PBS
for 10 min. IHC was performed with DAKO Cytomaton
Envision+ System (DAKO corporation, Carpinteria, CA,
USA) according to the following protocol. Sections were
blocked in 3% BSA in PBS for 1 h, and incubated with
primary antibodies in 1% BSA in PBS overnight at 4-C
(mouse anti-human BMP4 antibody dilution 1:50, rat anti-
mouse GCNA1 monoclonal antibody supernatant dilution
1:10, mouse anti-bovine vimentin 1:25). Slides were washed
in PBS with 0.05% Tween-20 (PBST), and incubated with
HRP-labeled polymer anti-mouse (anti-BMP4 and anti-
vimentin) or anti-rat (anti-GCNA1) secondary antibody
solutions (DAKO) for 45 min. Slides were washed in
PBST, then color development was performed using DAKO
Liquid DAB+ Substrate-Chromagen System according to
manufacturer’s protocol. Sections were then counterstained
with Gill’s hematoxylin.
Germ cell isolation, culture, and vitality staining
For isolation of spermatogonia, testes from 20 8-day-old
Swiss mice were pooled, while for pachytene spermatocytes
and round spermatids, mice of a minimum of 8 weeks old
were used. Testes were isolated, de-capsulated, and incu-
bated for 15 min each in 0.5 mg/ml collagenase/DMEM
with agitation and then in 0.25% trypsin/EDTA in DMEM.
Tubules were dissociated manually by pipetting and washed
in 0.5% BSA in DMEM by centrifugation. Cell pellets were
resuspended in DMEM and filtered twice through a 70 Am
membrane, then separated over a BSA gradient (Bellve et
al., 1977). Purified germ cells were identified by GCNA1
staining for spermatogonia (Richards et al., 1999) and
Arachis hypogaea lectin staining of the developing acro-
some for spermatocytes and spermatids. Acrosome staining
was performed as follows: cells were fixed for 10 min in
ice-cold methanol and dried onto slides. Slides were
incubated with 1 mg/ml lectin for 15 min, washed twice
in PBS, and mounted in 10% Mowiol 4–88 with 30%
glycerol in 0.2 M Tris (pH 8.5) with 2.5% 1,4-diazobicyclo-
(2.2.2)-octane (DABCO). Cells were categorized based on
both size and lectin staining pattern: spermatocytes
exhibited relatively diffuse staining localized to a region
representing the early stages of acrosome development, and
spermatids were scored based on distinct labeling of the
developing and elongating acrosome (data not shown).
Fractions were found to be greater than 90% pure for
spermatogonia based on GCNA1 positive cells, and with no
obvious somatic cell contamination. Spermatocyte fractions
were 65–70% pure with contaminating cells largely
consisting of early spermatocytes. Spermatids were 85–
95% pure with contaminating cells consisting of late
spermatocytes.Spermatogonia were either subjected to RNA or protein
isolation, or further cultured for 6 h in DMEM containing
10% FBS, in the presence or absence of retinoids before
extracting RNA. Cell vitalities were assessed by trypan blue
exclusion, and were found to be greater than 75% (data not
shown). Spermatocytes and spermatids were immediately
subjected to RNA or protein extraction following separation.
Each cell isolation experiment was repeated a minimum of 3
times.
RNA isolation
Total RNAwas isolated from cells using two rounds of a
modified acid guanidinium thiocyanate–phenol–chloro-
form protocol (Chomczynski and Sacchi, 1987): washed
cells resuspended in lysis buffer (4 M guanidinium
thiocyanate, 25 mM sodium citrate, 0.5% sarkosyl, 0.72%
h-mercaptoethanol). RNA was isolated by phenol/chloro-
form extraction and isopropanol precipitated.
Reverse transcription polymerase chain reaction (RT-PCR)
and cloning
Reverse transcription was performed with 2 Ag of total
RNA, 500 ng oligo-dT primer, 40 U of RNasin (MBI
Fermentas), 0.5 mM dNTPs, and 20 U of RevertAidi M-
MuLV-Reverse Transcriptase (MBI Fermentas). PCR reac-
tions contained cDNA equivalent to 100 ng of RNA, 80 ng
of each primer, 0.5 mM dNTPs, 1 U of Taq polymerase
(MBI Fermentas). Prior to analysis of gene expression, RT
reactions were verified by h-actin PCR. Primer sequences
are listed in Table 1, along with annealing temperatures.
BMP4 promoter primer sequences and PCRs were carried
out as previously described (Thompson et al., 2003). PCR
fragments were cloned into pGEM-T Easy (Promega)
according to manufacturer’s instructions, and sequenced
by Australian Genome Research Facility (AGRF, Brisbane,
Australia) to confirm insert sequences. Each PCR was
performed on 3 separate cell isolations, of which a
representative PCR is shown.
Real-time PCR
Real-time PCR was performed on cDNA generated as
described above, with the exception that prior to reverse
transcription, RNA was treated with DNAse to remove
genomic DNA contamination. Real-time PCR was per-
formed using SYBRR Green JumpStart Taq ReadyMix
(Sigma) according to manufacturer’s instructions on an
MJ Opticon 2 (MJ Research, Reno, NV, USA). Primer
sequences are provided in Table 1. Reactions were
performed on cDNA equivalent to 100 ng of total
RNA and carried out for 40 amplification cycles.
SYBRR Green fluorescence was measured after the
extension step at the end of each amplification cycle
and quantified using Opticon Monitor Analysis software
Table 1
Primer sequences and annealing temperatures
Gene Primer sequences Annealing
temperature
(-C)
RARa 5V-AGTTCCGAAGAGATAGTACC-3V 55
5V-ATGATGCAGTTCTTGTCC-3V
RARh 5V-CAGGAACAAGAAAAAGAAGG-3V 60
5V-GCAAAGGTGAACACAAGG-3V
RARg 5V-TCTTCAGACGCAGCATTC-3V 60
5V-CTCCTCTTTTCAATCCTTTTTC-3V
RXRa 5V-ATCTTTGACAGGGTGCTAC-3V 58
5V-CATACACCTCTCCCTCAAC-3V
RXRh 5V-TTTCTTCAAGCGCACCATTC-3V 60
5V-ATCTCCATCCCCGTCTTTGTC-3V
RXRg 5V-TACGGTGACATGAACGTGG-3V 60
5V-AGAAGGAGGCAATGAGCAG-3V
BMP4 5V-GAGGAGTTTCCATCACGAAGAA-3V 65
5V-CAGGAACCATTTCTGCTGGG-3V
Exon 1A
forward
primera
5V-GAAGGCAAGAGCGCGAGG-3V 60
Exon 1B
forward
primera
5V-CAGGCCGAAAGCTGTTC- 3V 60
Intron 2
forward
primera
5V-GAGCCTGTCTGCTCCAGAGTCTC-3V 60
BMP4
reverse
primer
(common)a
5V-ACGACCATCAGCATTCGGTTAC-3V 60
Exon 1A
forward
primer
(real-time
PCR)
5V-GACCAGGTTCATTGCAGCTTTC-3V 60
h-Actin 5V-AGCCTTCCTTCTTGGGTATG-3V 55–65
5V-CTTCTGCATCCTGTCAGCAA-3V
a Thompson et al. (2003).
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omitting the reverse transcription step was undertaken as
a negative control. Reverse transcription reactions were
verified by b-actin PCR, performed for each sample in
all reactions in triplicate. Real-time data were analyzed
using the equation 2DC(t), where C(t) is the cycle at
which fluorescence was first detected above background
fluorescence (Livak and Schmittgen, 2001). Data were
normalized to b-actin and then to a reference sample (see
figures) and are presented as the average of each replicate
normalized to each reference sample (TSEM). The
2DDC(t) transformation (Livak and Schmittgen, 2001)
was used for comparisons between retinoid-treated and
vehicle control primary spermatogonial cultures. Each of
these samples was examined in triplicate, and each data
set consists of at least 3 separate experiments (Fig. 9). In
this figure, values for each replicate were averaged, and
relative expression levels between retinoid-treated samples
are depicted as percentages of controls (TSEM). For
experiments involving retinoid readministration to VADanimals, each data point is the average of at least 3
separate animals.
In situ hybridization
Testes were isolated and fixed in 4% paraformaldehyde in
PBS at 4-C overnight, dehydrated, and embedded in
paraffin, and 7 Am sections were processed for in situ
hybridization. DIG-labeling of linearized probes was carried
out using the Roche (Roche Molecular Biochemicals,
Mannheim, Germany) DIG RNA Labelling Kit (SP6/T7)
according to manufacturer’s instructions. Probe detection
was carried out using a Roche anti-DIG alkaline phospha-
tase-conjugated antibody and NBT/BCIP (Roche) was used
for probe detection as per manufacturer’s instructions.
Sections were counterstained with Gill’s hematoxylin and
photographed under bright field microscopy using a Zeiss
Axioplan 2 compound microscope.
Protein extraction and Western blotting
Cells were solubilized with lysis buffer (4% CHAPS,
7 M urea, 2 M thiourea in 30 mM Tris, pH 8.5). Protein
concentration was estimated using a 2D Quant Kit
(Amersham). Soluble proteins were then precipitated with
ice-cold acetone and resuspended in SDS sample buffer
(375 mM Tris–HCL, 2% (w/v) SDS, and 10% (w/v)
sucrose, pH 6.8) containing 2% (v/v) h-mercaptoethanol,
and boiled at 100-C for 15 min. 10 Ag of each protein
sample and 10 ng of human recombinant BMP4 were
separated on a 12% polyacrylamide gel (Laemmli, 1970)
and transferred onto a nitrocellulose hybond C-Extra
membrane (Amersham) (Towbin et al., 1992) at 350 mA
constant current for 1.5 h. Membranes were blocked for 1
h in 5% skim milk powder in TBST (0.1% Tween-20),
then incubated with 2 Ag/ml of mouse anti-BMP4
monoclonal antibody or 125 ng/ml anti-vimentin mono-
clonal antibody in 1% milk powder in TBST overnight at
4-C. Membranes were washed in TBST, then incubated
with HRP-conjugated goat anti-mouse secondary antibody
(Santa Cruz) at a 1:3000 dilution for 1 h at room
temperature. Membranes were washed in TBST and
visualized using an ECL Detection Kit (Amersham
Biosciences) according to manufacturer’s instructions.
Membranes were then stripped in 100 mM h-mercaptoe-
thanol, 2% SDS, and 62.5 mM Tris (pH6.7) at 60-C for 1
h, and reprobed using anti-a-tubulin (Santa Cruz) as a
loading control. The Western blot image presented in
Results is representative of 3 replicate experiments.
Data analysis
Experiments were replicated at least 3 times prior to
statistical assessment by ANOVA. Post-hoc testing was
performed using Fischer’s PLSD. Samples with a P value of
<0.05 were considered significant (*).
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BMP4 mRNA and protein are expressed in spermatogonia
and early spermatocytes
Due to the lethal nature of the BMP4 knockout, few
studies exist that have examined BMP4 and its potential role
in spermatogenesis. Since BMP4 is known to play an
essential role in PGC formation, we examined the expres-
sion pattern of BMP4 mRNA in the adult mouse testis using
in situ hybridization. We detected BMP4 messenger RNA
expression at the earliest stages of spermatogenesis,
predominantly in the cytoplasm of the spermatogonia and
early spermatocytes (Fig. 1A), with decreased levels
detected in mid-stage spermatocytes. Hematoxylin counter-
staining was used to identify Sertoli cells, which did not
exhibit any staining for BMP4 (data not shown). No signal
was detected with BMP4 sense control probes (Fig. 1B).Fig. 1. Localization of BMP4 mRNA and protein expression in adult mouse semin
mRNA probes for either anti-sense (AS) or sense (S) BMP4 , and visu
Immunohistochemical analysis was performed on adult mouse testis sections,
HRP-conjugated secondary antibody. (A) Representative in situ hybridization analy
was detected primarily in the cytoplasm of spermatogonia and early spermatocytes
was detected in the BMP4 mRNA sense control. (Magnification: 200. Scale bar
expression characteristics of BMP4 protein in the adult mouse testis in (C) 40 m
Sertoli cells did not express detectable levels of BMP4 protein. (arrowhead = Se
hematoxylin. Vimentin staining is localized to Sertoli cell cytoplasm (Magnifica
secondary antibody used for vimentin staining is the same as in panel D.Immunolocalization experiments using an anti-BMP4
antibody revealed that the expression pattern of the BMP4
protein corresponded with that of the mRNA (Figs. 1C,
D). Staining tubules with anti-vimentin, a Sertoli cell-
specific protein (Show et al., 2003; Wang et al., 2002;
Zhang et al., 2004), confirmed that BMP4 expression was
not apparent in Sertoli cells (Fig. 1E). Thus, while it is
possible that a small amount of BMP4 levels could ori-
ginate in Sertoli cells, we believe that the overall ex-
pression of BMP4 in Sertoli cells in the adult mouse
testis is minimal.
Quantification of BMP4 levels in adult mouse testis and in
isolated germ cells
To determine definitively whether the BMP4 expression
we observed by in situ hybridization and immunohisto-
chemistry was solely due to germ cell expression, Westerniferous tubules. Adult mouse testis sections were probed with DIG-labeled
alized using an alkaline phosphatase-conjugated anti-DIG antibody.
using either anti-BMP4 or anti-vimentin monoclonal antibodies, and an
sis of BMP4 gene expression in mouse seminiferous tubules. BMP4 mRNA
, with decreased levels in late spermatocytes and spermatids. (B) No signal
: 40 Am). Representative immunohistochemical experiments demonstrating
agnification, and (D) 400 magnification counterstained with hematoxylin.
rtoli cell). (E) Vimentin (Vim) localization in a section counterstained with
tion: 400. Scale bar: 15 Am). (F) Secondary antibody only control. The
Fig. 3. Real-time PCR analysis of BMP4 gene expression in spermatogonia,
spermatocytes, and spermatids. Real-time PCR analysis was performed on
cDNA generated from total RNA from isolated germ cells to examine
relative expression levels of BMP4 mRNA. Data are presented as relative
levels of expression normalized to spermatogonia (TSEM). A statistically
significant decrease in BMP4 mRNA expression levels was observed from
spermatogonia (spg) to pachytene spermatocytes (spcyte), and from
spermatogonia to round spermatids (sptid) (P < 0.05).
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Through the use of an anti-human BMP4 antibody, we
were able to detect mouse BMP4 in whole adult mouse
testis and in isolated germ cells (Fig. 2). The membranes
were subsequently reprobed with anti-vimentin to demon-
strate the purity of germ cell populations, with no
detectable levels of vimentin in our germ cell fractions.
The expression of BMP4 in germ cells appeared highest in
spermatogonia, and decreased significantly in pachytene
spermatocytes and round spermatids. There were approx-
imately equal levels of BMP4 in spermatogonia and whole
testis, indicating that the BMP4 protein expression in the
testis can be largely attributed to germ cell expression
rather than that of any somatic cell expression. To obtain a
quantitative measure of the relative levels of BMP4
expression between each germ cell fraction, we then
utilized quantitative real-time PCR.
Real-time PCR analysis confirmed the gene and protein
expression data, and is presented as the relative levels of
BMP4 mRNA for spermatogonia, pachytene spermato-
cytes, and round spermatids, normalized to h-actin (TSEM;
Fig. 3). Significantly greater levels of BMP4 mRNA
expression were detected in spermatogonia relative to
spermatocytes and spermatids (P < 0.05, n = 4).
Collectively, the Western and real-time PCR data illustrate
that the majority of the BMP4 expressed in adult mouse
testis can be attributed to spermatogonial and early
spermatocyte gene expression.
Regulation of BMP4 mRNA and protein levels during
vitamin A deficiency (VAD)
As a result of VAD, the only remaining germ cells in the
testes are spermatogonia (reviewed in Chung and Wolge-
muth 2004). Since BMP4 mRNA and protein expression
were highest in spermatogonia and BMP4 is regulated by
retinoids in other cellular systems, we investigated whether
retinoids were able to influence BMP4 mRNA expression
in the VAD testis (Fig. 4). We generated vitamin AFig. 2. Western blot showing localization of BMP4 protein in isolated germ
cells. CHAPS extracted proteins from testes and isolated germ cells were
subjected to Western blotting with anti-BMP4, anti-vimentin, and anti-a-
tubulin antibodies. BMP4 is located primarily in spermatogonia (spg), with
almost no levels detected in pachytene spermatocytes (spcytes) and round
spermatids (sptids). A whole testis extract is provided for comparison. a-
Tubulin was used as a loading control. Vimentin Western blotting was
performed to determine Sertoli cell contamination in germ cell fractions,
and shows no detectable levels of vimentin in germ cell fractions.deficient mice, and then quantitatively measured the levels
of BMP4 mRNA in testis samples from these mice
compared to fertile control animals. The vitamin A
deficient phenotype exhibited in these animals was typical,
with seminiferous tubules containing only Sertoli cells and
spermatogonia. Interestingly, we found a 7-fold increase in
BMP4 mRNA expression levels (as assessed by real-time
PCR) in the testes of VAD mice compared with controlFig. 4. Analysis of BMP4 mRNA levels in the vitamin A deficient testis.
Total RNA was collected from the testes of vitamin A deficient adult male
mice, and real-time PCR on cDNA generated from these samples was used
to examine the levels of BMP4 mRNA in the absence of retinoids. Data are
presented as the relative levels of expression between control testes samples
and VAD samples, normalized to VAD (TSEM). A significant increase in
BMP4 mRNA levels was observed in the absence of retinoids (P < 0.01).
(Control = complete spermatogenesis, VAD = vitamin A deficient).
Representative images are provided of the testicular morphology of VAD
animals, and control (C) animals for comparison (Counterstained with
hematoxylin. Magnification: 200).
R.M. Baleato et al. / Developmental Biology 286 (2005) 78–9084animals (Fig. 4), thus demonstrating that the enrichment for
spermatogonia resulted in a significant increase in BMP4
protein levels.
To examine whether these results were solely due to an
enrichment of cells expressing BMP4, we examined BMP4
protein levels during progressive stages of vitamin A
deficiency. When testicular samples were collected from
mice in progressive states of VAD (from incomplete to
complete VAD), it was observed that partially deficient mice
experienced an increase in the number of cells staining
positive for BMP4, as determined by immunolocalization
studies (Fig. 5). As mice progressed towards more extreme
cases of VAD, an increased number of apoptotic cells were
observed. These can be seen in Fig. 5F, where they appear
as large multinucleate cells, and stain positive in TUNEL
assays (data not shown). In these cells, BMP4 is no longer
detectable. As complete deficiency is finally reached,
staining is localized to spermatogonia only (Figs. 5G–I).
These results document an initial increase in BMP4 positive
cells in the partially VAD testis which is then followed by
the appearance of BMP4-negative apoptotic cells. The
process culminates in the depletion of germ cells in the
seminiferous tubules after prolonged VAD, leaving only
spermatogonia, which retain BMP4 expression. These
results suggest that BMP4 positive germ cells are the only
germ cells remaining under conditions of VAD.Fig. 5. BMP4 immunolocalization in seminiferous tubules at progressive stages of
at progressive stages of vitamin A deficiency. Tissue was processed for histology
analysis revealed a progressive increase in the number and type of cells expressin
localization. (B, C) BMP4 staining (brown) in seminiferous tubules from control
stained mouse testis at an early stage of VAD (6 weeks post-weaning). The number
showing apoptotic cells (Ap). (G) Bright field image showing BMP4 staining patt
BMP4 negative germ cells and BMP4 staining is now localized to cells arou
magnification showing specific staining in spermatogonia (arrowheads). Scale baROL but not RA preferentially initiates a rapid decrease in
BMP4 in VAD
To determine whether testicular BMP4 was regulated by
retinoids in vivo, VAD mice were treated with either RA or
ROL. Mice received an initial inter-peritoneal injection of
either RA or ROL, and were then maintained on a diet
containing either RA or ROL, respectively. Real-time PCR
analysis revealed that ROL administration for 24 h, led to a
decrease in BMP4 mRNA expression in the VAD testis.
Similar treatments with RA did not affect BMP4 mRNA
levels. This down-regulation of BMP4 gene expression by
ROL was significant when compared to RA treatment (Fig.
6). Since a 24-h treatment with either retinoid is not
sufficient to significantly alter the cellular composition of
the VAD testis (Fig. 6), the observed differences in relative
BMP4 levels could not be attributed to enrichment for cells
expressing BMP4.
VAD mice were also treated with RA or ROL for 21
or 19 days, respectively. It was apparent that 21 days of
RA treatment were not sufficient to reinitiate spermato-
genesis. However, in contrast, 19 days of ROL treatment
were sufficient for the resumption of spermatogenesis
(Fig. 7). It was apparent upon quantification of BMP4
mRNA that, similar to 24 h of ROL administration, 19
days of ROL administration significantly down-regulatedvitamin A deficiency. VAD mice were generated as described, and sampled
, and BMP4 was localized with anti-human BMP4. Immunohistochemical
g BMP4 protein as VAD status increased. (A) Bright field image of BMP4
animals counterstained with hematoxylin. (D) Bright field image of BMP4
of cells staining positive for BMP4 increased. (E, F) Counterstained images
ern of 7-week deficient VAD testis. The tubule no longer contains late stage
nd the basement membrane. (H, I) Counterstained images at increased
r: approximately 10 Am.
Fig. 7. Real-time PCR analysis of BMP4 mRNA levels in adult VAD mouse
testis after prolonged retinoid administration. VAD mice were administered
either RA for 21 days or ROL for 19 days to instigate recovery of
spermatogenesis, and relative levels of BMP4 mRNA expression was
examined through real-time PCR. Data are presented as the relative levels
of expression of BMP4 mRNA normalized to RA (TSEM). Results show
that a significant decrease in BMP4 mRNA levels is maintained 19 days
after ROL administration, compared to 21 days with RA (P < 0.05).
Hematoxylin stained representative images of RA or ROL administered
testes are provided for histological analysis of spermatogenic recovery.
Fig. 6. Real-time PCR analysis of BMP4 mRNA levels in adult VAD mouse
testis 24 h after retinoid administration. VAD mice were readministered
either RA or ROL and total RNA was collected from the testes of these
animals 24 h post-retinoid administration. BMP4 mRNA levels were
examined through real-time PCR on cDNA from these samples. Data are
presented as the relative levels of expression of BMP4 mRNA normalized
to RA (TSEM). Hematoxylin stained images of testes treated with either
ROL or RA for 24 h (representative images) are provided for histological
comparison. Results show a significant decrease in BMP4 mRNA levels
after ROL administration compared to RA (P < 0.01).
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with the 24-h time point, 21 days of RA treatment had
no effect on BMP4 gene expression. This confirmed that
BMP4 expression in the adult mouse testis is retinoid
dependent. However, interestingly, these results showed
that ROL, and not RA, was the active retinoid
metabolite.
Retinol regulates BMP4 mRNA in spermatogonia
To examine whether the effect of ROL on BMP4 levels
in the VAD testis was mediated by Sertoli cells, or as a
direct effect of ROL on germ cells, we examined the effect
of retinoid treatment on BMP4 gene expression in isolated
spermatogonia. Primary cultures of spermatogonia were
incubated for 6 h in the presence of 1 AM RA, 1 AM ROL,
or a vehicle control (ethanol). Data are presented as the
expression of BMP4 mRNA in retinoid-treated spermato-
gonia relative to control levels (TSEM) (Fig. 8). We again
found a marked down-regulation of BMP4 gene expres-
sion, and this was statistically significant after ROL (P <
0.05, n = 8) but not RA treatment. These results illustrate
that isolated spermatogonia are more responsive to ROL
than RA in terms of the regulation of the expression of
BMP4 and possibly other genes, and the effects observed
above are a result of ROL acting directly on germ cell
gene expression, rather than an indirect effect mediated by
Sertoli cells.
Retinoid receptor expression in spermatogenic cells at
various stages of differentiation
Since we had demonstrated a regulation of BMP4 levels
in germ cells in response to retinoids, we examined gene
expression for the retinoid receptors using RT-PCR.
Messenger RNA for RARa, RARc, and all of the RXRsFig. 8. Effect of retinoid treatment on BMP4 mRNA expression in isolated
spermatogonia. Spermatogonia were isolated from 8-day-old testes and
cultured for 6 h in the presence of either 1 AM RA, 1 AM ROL, or ethanol
vehicle control. Total RNA was then isolated and real-time analysis was
performed on cDNA generated from these samples to examine BMP4
mRNA levels. Treatment of spermatogonia with of 1 AM ROL for 6 h
decreased BMP4 gene expression in spermatogonia significantly (P <
0.05). Treatment with 1 AM RA for 6 h induced a slight decrease in BMP4
mRNA levels relative to untreated spermatogonia; however, this was not
statistically significant. Data were presented as percentage of control levels
(TSEM).
Fig. 9. Retinoid receptor expression in spermatogonia. Reverse transcription (RT)-PCR was performed on cDNA generated from total RNA isolated from
spermatogonia to examine the expression of the retinoid receptors. Negative control samples where reverse transcriptase was omitted are included (RT). (A)
Spermatogonia express all the RXRs, RARa, and RARg. h-Actin was used as an RT control. (B) RARb mRNA was not detectable in spermatogonia (spg),
spermatocytes (spcytes), or spermatids (sptids). (C) RARh mRNA expression could not be induced after treatment with either 1 AM RA or ROL for 6 h (6 h).
RA-treated P19 embryonal carcinoma cells were used as a positive control for all RARh PCRs.
Fig. 10. BMP4 promoter utilization in mouse germ cells. Total RNA was
isolated from spermatogonia from 8-day-old testes, and from GC-1 (spg).
RT-PCR for the 1A, 1B, and i2 promoter-specific transcripts was used to
examine promoter usage in germ cells. PCR results indicate the presence
of BMP4 promoter-specific transcripts arising from transcription from the
1A and 1B promoters, and from the i2 promoter. The GC-1(spg) cell line
also utilized all three BMP4 promoters. h-Actin was used as an RT control
(spg = spermatogonia). Samples omitting reverse transcriptase are included
as negative controls (RT).
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however, RARb mRNA could not be easily detected in
spermatogonia.
We further analyzed the expression of RARb in isolated
spermatogonia, spermatocytes, and spermatids, and found
extremely low levels of RARb mRNA, at the limits of
detection by PCR (Fig. 9B). To verify this result, the P19
embryonal carcinoma cell line was used as a positive control
as an example of RARh induction upon retinoid treatment,
and as an RARh PCR control (Fig. 9C). The paradigm
response to retinoid treatment is RARb induction, as the
gene encoding RARh contains an RA response element
(RARE) in the promoter region, and RARh expression is
classically up-regulated in response to RA treatment (de The
et al., 1990; Kobayashi et al., 2000; Sucov et al., 1990).
Thus, we expected RARb mRNA to increase in response to
RA treatment. However, RARb was not inducible by
retinoid treatment in spermatogonia treated for 6 h with
either RA or ROL (Fig. 9C).
BMP4 promoter expression in mouse germ cells and the
VAD testis
As described previously, retinoid down-regulation of
BMP4 gene expression is not unique to the mouse germ
line. In one particular study, Thompson et al. (2003)
described a mechanism by which BMP4 gene expression
could be down-regulated by RA in the mouse inner ear.
They determined the existence of a novel promoter in the
second intron of the BMP4 gene, which mediated this
BMP4 response to RA in both an inner ear-derived cell line
(2B1) and in isolated otocysts. Previously, the existence of
two promoters (1A and 1B) had been documented (Feng et
al., 1995), with 1A being predominantly active in most celltypes (Feng et al., 1995). We used RT-PCR with the
promoter-specific transcript primers used by Thompson et
al. (2003) to examine whether these BMP4 promoters were
active in isolated spermatogonia. For this study, the
immortalized mouse spermatogonial cell line GC-1(spg)
was also used as a control. This cell line is thought to exhibit
an intermediary phenotype between type A and type B
spermatogonia, and has been found to express several germ
cell markers, including the germ-cell-specific BMP, Bmp8b
(unpublished results). We found promoter 1A and the intron
2 promoter product (termed i2) to be expressed in both
spermatogonia and GC-1(spg) (Fig. 10). The 1B tran-
scription product was also detected in germ cells, although
they were found to have a shortened exon 1B, based on the
size of the 1B transcription product. Thompson et al. (2003)
similarly observed this in 2B1 cells, where the 1B exon
could be expressed as either 21 or 279 base pairs in length.
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we were not able to detect the presence of the 279 base pair
exon through RT-PCR.
At present, few studies exist where germ cells have been
successfully transfected, and germ cells are notoriously
difficult to culture for extended periods of time. Thus,
BMP4 promoter analysis in germ cells through the use of
reporter construct assays is problematic. Therefore, in order
to analyze BMP4 promoter utilization in the VAD testis, we
carried out real-time PCR analysis on the promoter PCR
products shown in Fig. 10. For 1A, another primer to that
used by Thompson et al. (2003) was designed to amplify a
smaller transcript within the same region, so the resulting
200 base pair product could be measured by SybrR Green
analysis (primer sequence is provided in Table 1). We
performed our studies on testicular tissue from mice
sampled 24 h after the administration of either RA or
ROL, to determine if the decrease in BMP4 mRNA levels
after ROL treatment of VAD mice was attributable to the
activity of a particular BMP4 promoter. Based on the
relative expression levels of these promoter-specific tran-
scripts, we found that the activity of both the 1A and i2
promoters was reduced in response to treatment by ROL,
but not by RA (Fig. 11). The activity of the 1B promoter
was found to be so low in both RA- and ROL-treated tissue,
that a functional analysis of this particular promoter was not
possible. This conclusion is based on the high C(t) values of
the PCR product downstream of the 1B promoter and the
difficulty in visualizing a 1B product after touchdown PCR
(as described in Thompson et al., 2003). Thus, it can be
assumed that the majority of BMP4 signaling in response to
retinoids in the adult mouse testis is due to the activity of
both the 1A and i2 promoters, and that both promoters are
responsible for the down-regulation of BMP4 mRNA levels
in response to ROL during spermatogenesis.Fig. 11. Analysis of promoter utilization in VAD testis using real-time PCR.
VAD mice were administered either RA or ROL for 24 h, and total RNA
was collected from testes at the end of each treatment. Real-time PCR on
promoter-specific transcripts was used to analyze BMP4 promoter activity
24 h post-retinoid administration. 1B promoter-specific transcript expres-
sion levels were below the limits of accurate detection with this assay.
Results are presented as the relative levels of expression normalized to 1A
transcript levels in RA administered testes (TSEM). A significant decrease
in relative transcript levels was seen for both the 1A and i2 promoters after
ROL treatment when compared to corresponding RA administered animals
( P < 0.05).Discussion
The molecular mechanisms underlying the induction of
infertility in VAD rodents have never been fully elucidated.
In addition, while several genes have been implicated in
spermatogenesis, relatively little is known regarding the
regulation of gene expression in the mammalian testis.
Several studies have attempted to characterize the genes
involved in spermatogenesis (Schultz et al., 2003) but, at
present, little is known regarding the function of such genes
or the significance of the signal transduction pathways they
mediate. Here, we report an interaction between two
signaling pathways in germ cells, that is supported by
observations in other differentiation processes, and that
provides insights into the role of retinoid metabolism in
spermatogenesis.
It has been well documented that BMP4 is necessary for
the generation and survival of PGCs and might therefore be
involved in the developmental regulation of spermato-
genesis. We found that adult germ cells expressed BMP4
at both mRNA and protein level. In the adult testis, BMP4
mRNA expression was found to be predominant in the early
germ cells, including spermatogonia and early spermato-
cytes, with expression being absent from Sertoli cells. We
found this pattern of expression by in situ hybridization,
immunohistochemistry, Western blotting, and immunohis-
tochemical analysis. Hu et al. (2004) found BMP4 mRNA to
be localized to spermatocytes, and to a lesser extent other
germ cells. While we also found germ cell localization, our
in situ hybridization data describe a different pattern of
expression, in that BMP4 was localized to earlier stages of
spermatogenesis than found by Hu et al. (2004). Our studies
using freshly isolated germ cells confirm maximal BMP4
expression in spermatogonia.
Recently, a paper by Pellegrini et al. (2003) detailed a
functional SMAD signaling network in isolated germ cells,
which was triggered by BMP4 treatment. These authors
described the expression of the BMP4 receptors, Alk-3 and
BMP receptor II, in spermatogonia but not spermatocytes.
Using Northern blot analysis, BMP4 mRNA was found to
be expressed in Sertoli cells from 4- and 7-day-old mice,
and then down-regulated in the 10- and 17-day-old mouse
testis. However, no BMP4 gene expression was detectable
in spermatogonia, spermatocytes, or spermatids. Our results
contradict this, as we were able to detect BMP4 expression
in germ cells through the use of several sensitive techniques,
and as previously mentioned, Hu et al. (2004) also detected
BMP4 mRNA in spermatocytes. The disparity between
these data could be due to different temporal patterns of
expression in different cell types whereby Sertoli cells
express BMP4 at post-natal days 4–7, with a subsequent
decline. However, Hu et al. (2004) describe BMP4 mRNA
expression in 1, 2, and 3-week-old testis sections and state
that germ cells in these tubules express BMP4. Moreover, at
day 8, we detect germ cell expression of BMP4 and, in the
adult, BMP4 appears to be exclusively expressed in the
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for in situ hybridization were all confirmed through DNA
sequencing, and the in situ staining patterns are in
accordance with immunohistochemical results. While we
cannot definitively state that Sertoli cells do not express any
BMP4, we believe that the amount of BMP4 in these cells,
if any, is difficult to detect above background using
conventional techniques.
As a consequence of VAD, there is an increase in
apoptotic cell numbers ultimately resulting in depletion of
all germ cells with the exception of BMP4 positive
spermatogonia. Subsequent readministration of ROL to
VAD animals caused a rapid decrease in BMP4 mRNA
levels after 24 h, which was maintained after 19 days of
treatment, which coincided with a resumption of spermato-
genesis. A similar exposure to RA did not affect overall
BMP4 mRNA levels in the VAD testis, nor could it support
spermatogenesis. The finding that ROL is more effective
than RA in suppressing BMP4 is in keeping with a wealth of
data indicating that ROL can reinitiate spermatogenesis,
while a similar dose of RA cannot. The only reported case
where RA was able to restore spermatogenesis was when it
was injected in large repeated doses into VAD rats (van Pelt
and de Rooij, 1991). The conclusion is, therefore, that RA is
metabolized rapidly leading to lower effective testis
concentrations than when ROL is provided. It is clear from
our studies that the down-regulation in BMP4 mRNA in
vitro correlates with the reinitiation of spermatogenesis. The
observed decrease in BMP4 gene expression in ROL-treated
isolated spermatogonia confirms that the germ cells
themselves are responsible for this down-regulation of
BMP4, and that they themselves can respond directly to
retinoids.
A core observation in this study was that the expression
of BMP4 is regulated by ROL in freshly isolated germ cells.
Previously, it had been suggested that Sertoli cells metab-
olized ROL to RA for delivery to the germ cells (reviewed
in Chung and Wolgemuth 2004). This paper documents the
direct response of germ cells suggesting that the necessary
metabolic activity may reside in these cells. Our results
indicate that the relative efficacy of ROL over RA in terms
of BMP4 regulation is evident even when the germ cells are
exposed directly to these retinoids. This would suggest that
retinoid metabolism is not restricted to somatic cells but can
occur in germ cells as well.
In the developing mouse ear, BMP4 is similarly down-
regulated by retinoids; however, in this case, the active
retinoid metabolite is all-trans-RA (Thompson et al., 2003).
Down-regulation of BMP4 gene expression by RA was
mediated by a direct interaction of RARa and RARg on a
novel BMP4 promoter (termed the i2 promoter) in both an
otocyst cell line and in the embryonic inner ear in vivo,
indicating that the retinoid receptors directly regulate BMP4
gene expression in this system. We have now found the i2
promoter to be active in germ cells, and that germ cells
contain a shortened 1B exon, as described in otocyst cells byThompson et al. (2003). In order to examine promoter
activity in germ cells, which are difficult both to culture
long term and to transfect, we used real-time PCR to analyze
the relative expression levels for the three promoter-specific
transcripts of the 1A, 1B, and intron 2 promoters. We found
the 1B promoter to be expressed at extremely low levels in
the control testis, the VAD testis, and in isolated germ cells.
However, analysis of the 1A and i2 promoter-specific
transcripts revealed that both promoters were involved in
the down-regulation of BMP4 mRNA levels in response to
ROL supplementation of VAD mice. Thus, the ROL-
mediated down-regulation of BMP4 in germ cells involves
the regulation of both the 1A and i2 promoters.
Whether the down-regulation of BMP4 levels by ROL is
a direct effect mediated by the interaction of retinoid
receptors and the promoter region of the BMP4 gene, or
whether other retinoid-regulated proteins mediate this effect
remains to be examined. Sequence analysis of the BMP4
gene has revealed the existence of several direct repeats and
potential RAREs in the 1A intron region (Feng et al., 1995;
Helvering et al., 2000). However, the ability of retinoid
receptors to bind directly to these sites and regulate gene
transcription has not been determined. In an inner ear cell
line, Thompson et al. (2003) provided evidence that RARs
mediate RA regulation of BMP4 gene expression. The
applicability of these results to the germ line remains to be
elucidated.
Our observations regarding retinoid receptor gene
expression in germ cells show not only that this regulation
is not mediated by RARh, but also provide evidence that the
response of germ cells to retinoids is atypical. RARb mRNA
was barely detectable in spermatogonia, and nor could the
RARb message be induced by RA treatment after 6 h of
culture. However, 6 h of retinoid treatment were sufficient to
effect a profound change in BMP4 levels. This result was
unusual, since in all other retinoid-responsive cells, RARb
mRNA is induced in response to retinoid treatment (de The
et al., 1990; Hoffmann et al., 1990; Leroy et al., 1991a,b;
Lin et al., 2000; Mendelsohn et al., 1991; Roy et al., 1995;
Sucov et al., 1990). The presence of the other retinoid
receptors in isolated spermatogonia corresponds with
previous studies showing the expression of all the known
retinoid receptors in both mouse and rat germ cell lineages
(Boulogne et al., 1999; Dufour and Kim, 1999; Gaemers et
al., 1998). The presence of these receptors indicates that a
functional retinoid signaling network exists in germ cells;
however, the absence of induction of RARb expression
highlights the possibility that a unique retinoid signaling
pathway exists in mouse germ cells.
In conclusion, this study suggests that retinoid signaling
in male germ cells is atypical. We have provided novel
evidence indicating that in vitro mouse spermatogenic cells
are able to respond directly to ROL. Germ cells respond to
this retinoid by down-regulating BMP4 mRNA expression,
via mechanisms that are not mediated by RARh. In vivo
BMP4 positive cells are all that remain once VAD is
R.M. Baleato et al. / Developmental Biology 286 (2005) 78–90 89achieved. This would suggest that the effects described for
germ cells in vitro also apply to germ cells in vivo. This
down-regulation of BMP4 in mouse spermatogonia may be
associated with their passage through a developmental
gateway, allowing them to continue differentiation into
more mature cell types.Acknowledgments
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